MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population (MEGASET HR)
A Randomized, Assessor-blind Trial Comparing MENOPUR® (Menotropins for Injection) and Recombinant FSH (Follicle Stimulating Hormone) in a GnRH Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population
Sponsor: Ferring Pharmaceuticals
A PHASE4 clinical study on Infertility, this trial is completed. The trial is conducted by Ferring Pharmaceuticals and has accumulated 12 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Oct 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Oct 2023 [monthly]
Completed PHASE4
▶ Show 7 earlier versions
-
Apr 2019 — Jan 2021 [monthly]
Completed PHASE4
-
Jun 2018 — Apr 2019 [monthly]
Completed PHASE4
-
Mar 2018 — Jun 2018 [monthly]
Completed PHASE4
-
Oct 2017 — Mar 2018 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Apr 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE4
-
Feb 2017 — Apr 2017 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ferring Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .